Detalhe da pesquisa
1.
Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results.
AIDS
; 19(2): 145-52, 2005 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-15668539
2.
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adults.
Clin Infect Dis
; 39(7): 1038-46, 2004 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15472858
3.
Abacavir once or twice daily combined with once-daily lamivudine and efavirenz for the treatment of antiretroviral-naive HIV-infected adults: results of the Ziagen Once Daily in Antiretroviral Combination Study.
J Acquir Immune Defic Syndr
; 38(4): 417-25, 2005 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15764958
4.
Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir.
Ann Pharmacother
; 38(12): 2171-2, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15536137